Get started
Author

David R. Jesudason

Observed names: D Jesudason, D R Jesudason, D. Jesudason, D.R. Jesudason, DAVID JESUDASON, David Jesudason, David R Jesudason, Jesudason, David
Observed institutions: South Australia Pathology, Commonwealth Scientific and Industrial Research Organisation, Royal Adelaide Hospital, University of South Australia, John Hunter Hospital, Hammersmith Hospital, Sir Charles Gairdner Hospital, Basil Hetzel Institute, Cabrini Hospital, Queen Elizabeth Hospital, Health Sciences and Nutrition, Australian Centre for Sexual Health, SA Health, South Australian Health and Medical Research Institute, Keogh Institute for Medical Research, Freemasons Foundation Centre for Men's Health, Animal, Food and Health Sciences, Central Adelaide Local Health Network, Adelaide University, Imperial College London, The University of Adelaide, University of Newcastle Australia
ORCID: 0000-0002-2026-3671
Observed ORCID: 0000-0002-2026-3671
OpenAlex ID: A5008192733
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial
2020 · Gary Wittert, Karen Bracken, et al. · The Lancet Diabetes & Endocrinology · 373
Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review
2019 · Venkatesan Thiruvenkatarajan, Emily Jane Meyer, et al. · British Journal of Anaesthesia · 207
Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency
2002 · D Jesudason, A.G Need, et al. · Bone · 157
SGLT2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications
2018 · Emily J. Meyer, Genevieve Gabb, et al. · Diabetes Care · 110
Low-dose pancreatic polypeptide inhibits food intake in man
2007 · David R. Jesudason, Mariana P. Monteiro, et al. · British Journal Of Nutrition · 85
PDF
Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts
2013 · David R Jesudason, Eva Pedersen, et al. · American Journal of Clinical Nutrition · 83
Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT
2021 · Mark Ng Tang Fui, Rudolf Hoermann, et al. · The Journal of Clinical Endocrinology & Metabolism · 81
Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes
2003 · David R. Jesudason, Kerrie Dunstan, et al. · Diabetes Care · 75
PDF
The interaction between dietary protein and bone health
2010 · David Jesudason, Peter Clifton · Journal of Bone and Mineral Metabolism · 74
Sustained effects of a protein ‘preload’ on glycaemia and gastric emptying over 4 weeks in patients with type 2 diabetes: A randomized clinical trial
2015 · Jing Ma, David R. Jesudason, et al. · Diabetes Research and Clinical Practice · 71
Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium–Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction
2023 · Mahesh M. Umapathysivam, James Gunton, et al. · Diabetes Care · 62
PDF
Comparison of 2 weight-loss diets of different protein content on bone health: a randomized trial
2013 · David Jesudason, BE Christopher Nordin, et al. · American Journal of Clinical Nutrition · 44
Endocannabinoid system in food intake and metabolic regulation
2008 · David Jesudason, Gary Wittert · Current Opinion in Lipidology · 43
Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician
2011 · D R Jesudason, P Clifton · International Journal of Obesity · 38
Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium–Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy
2020 · Emily J. Meyer, Edward Mignone, et al. · Diabetes Care · 37
PDF
High protein weight loss diets in obese subjects with type 2 diabetes mellitus
2013 · E. Pedersen, D.R. Jesudason, et al. · Nutrition Metabolism and Cardiovascular Diseases · 36
No evidence of an additive inhibitory feeding effect following PP and PYY3−36 administration
2008 · N M Neary, B M McGowan, et al. · International Journal of Obesity · 33
Young‐onset colorectal cancer is associated with a personal history of type 2 diabetes
2020 · Reger R. Mikaeel, Erin L. Symonds, et al. · Asia-Pacific Journal of Clinical Oncology · 31
Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies
2019 · Karen Bracken, Wendy Hague, et al. · Trials · 28
PDF
The bacteriology of diabetic foot ulcers and infections and incidence of Staphylococcus aureus Small Colony Variants
2023 · James Lee, Matipaishe Mashayamombe, et al. · Journal of Medical Microbiology · 25
SGLT2 Inhibitor–Associated Ketoacidosis vs Type 1 Diabetes–Associated Ketoacidosis
2024 · Mahesh M. Umapathysivam, Bethany Morgan, et al. · JAMA Network Open · 24
PDF
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial
2023 · Kristy P Robledo, Ian C Marschner, et al. · European Journal of Endocrinology · 21
PDF
A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: A randomised, double-blind, parallel-group, placebo-controlled study in Australian men
2005 · C.G. McMahon, B.G.A. Stuckey, et al. · International Journal of Clinical Practice · 19
PDF
Obstructive sleep apnea is not an independent determinant of testosterone in men
2020 · Brigette Marie Clarke, Andrew D Vincent, et al. · European Journal of Endocrinology · 17
The effect of obesity interventions on male fertility: a systematic review and meta-analysis
2025 · Andrew Peel, Hannah Lyons, et al. · Human Reproduction Update · 15
PDF
Works count: 78
Citation count: 1,914
H-index: 21
I10-index: 28
Year
Topic
Type